Christopher Plummer

Christopher Plummer currently serves as Director of In vitro Antibody Discovery at GSK, where responsibilities include program management and acting as a scientific liaison for external therapeutic collaborations. With a career at GSK starting in March 2007, Christopher has held various positions, including Associate Director and Interim Head of Antibody Lead Discovery, and possesses expertise in matrix and line management, technology development, and antibody library design. Prior experience includes a role as Senior Scientist at Domantis, which was acquired by GSK in 2007. Academic qualifications include a PhD in Molecular and Structural Biology and Enzymology from the University of Leeds and a BSc in Biochemistry with Molecular Biology and Biotechnology from the University of Bristol.